Skip to main content
NCBI home page
Gut logoLink to Gut
. 1990 Jan;31(1):96–99. doi: 10.1136/gut.31.1.96

Raised histamine concentrations in chronic cholestatic liver disease.

S D Gittlen 1, E S Schulman 1, W C Maddrey 1
PMCID: PMC1378348  PMID: 2108078

Abstract

Pruritus is a frequent symptom in chronic cholestatic liver disease. To date, no single causative mechanism has been identified. We examined venous plasma concentrations of the known pruritogen, histamine, using a highly sensitive radioenzymatic assay in 42 patients with chronic cholestatic liver disease, and in normal controls. The mean plasma histamine level was significantly greater in chronic cholestatic liver disease patients (275 (117) pg/ml; X (SD) than in controls (140 (72) pg/ml, n = 20) (p less than 0.0001). No significant differences were found between histamine concentrations in the two chronic cholestatic liver disease subgroups: primary biliary cirrhosis and sclerosing cholangitis. Histamine concentrations were significantly greater (p less than 0.01) in the pruritic (319 (132) pg/ml) as compared with the non-pruritic (227 (75) pg/ml) chronic cholestatic liver disease patients. The histaminase activity was equivalent in patients and controls. The finding of raised histamine concentrations in chronic cholestatic liver disease suggests in vivo mast cell activation and a potential role for its mediators in the pruritus characteristic of these disorders.

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asad S. I., Murdoch R., Youlten L. J., Lessof M. H. Plasma level of histamine in aspirin-sensitive urticaria. Ann Allergy. 1987 Sep;59(3):219–222. [PubMed] [Google Scholar]
  2. Atkins P. C., Valenzano M., Zweiman B. Plasma concentrations of histamine measured by radioenzymatic assay: effects of histaminase incubations. J Allergy Clin Immunol. 1982 Jan;69(1 Pt 1):39–45. doi: 10.1016/0091-6749(82)90085-9. [DOI] [PubMed] [Google Scholar]
  3. Barth H., Kapp B., Crombach M., Priesack W., Lorenz W. Histamine storage and metabolism of human liver in disorders of the biliary tract. Agents Actions. 1980 Apr;10(1 Pt 2):101–104. doi: 10.1007/BF02024187. [DOI] [PubMed] [Google Scholar]
  4. Duncan J. S., Kennedy H. J., Triger D. R. Treatment of pruritus due to chronic obstructive liver disease. Br Med J (Clin Res Ed) 1984 Jul 7;289(6436):22–22. doi: 10.1136/bmj.289.6436.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Freedman M. R., Holzbach R. T., Ferguson D. R. Pruritus in cholestasis: no direct causative role for bile acid retention. Am J Med. 1981 May;70(5):1011–1016. doi: 10.1016/0002-9343(81)90857-3. [DOI] [PubMed] [Google Scholar]
  6. Garden J. M., Ostrow J. D., Roenigk H. H., Jr Pruritus in hepatic cholestasis. Pathogenesis and therapy. Arch Dermatol. 1985 Nov;121(11):1415–1420. [PubMed] [Google Scholar]
  7. Ghent C. N., Bloomer J. R., Klatskin G. Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus. Gastroenterology. 1977 Nov;73(5):1125–1130. [PubMed] [Google Scholar]
  8. Gleich G. J., Hull W. M. Measurement of histamine: a quality control study. J Allergy Clin Immunol. 1980 Oct;66(4):295–298. doi: 10.1016/0091-6749(80)90024-x. [DOI] [PubMed] [Google Scholar]
  9. Herndon J. H., Jr Itching: the pathophysiology of pruritus. Int J Dermatol. 1975 Sep;14(7):465–484. doi: 10.1111/j.1365-4362.1975.tb04281.x. [DOI] [PubMed] [Google Scholar]
  10. Ishii K., Suzuki O., Maruyama K., Nagata H., Kiryu Y., Tsuchiya M. Therapeutic effect of histidine decarboxylase inhibitor on chronic active hepatitis. Gastroenterol Jpn. 1978;13(2):105–110. doi: 10.1007/BF02773855. [DOI] [PubMed] [Google Scholar]
  11. SCHAFFNER F. CHOLESTYRAMINE, A BOON TO SOME WHO ITCH. Gastroenterology. 1964 Jan;46:67–70. [PubMed] [Google Scholar]
  12. SCHAYER R. W. Evidence that induced histamine is an intrinsic regulator of the microcirculatory system. Am J Physiol. 1962 Jan;202:66–72. doi: 10.1152/ajplegacy.1962.202.1.66. [DOI] [PubMed] [Google Scholar]
  13. Sampson H. A., Jolie P. L. Increased plasma histamine concentrations after food challenges in children with atopic dermatitis. N Engl J Med. 1984 Aug 9;311(6):372–376. doi: 10.1056/NEJM198408093110605. [DOI] [PubMed] [Google Scholar]
  14. Schulman E. S. The role of mast cell derived mediators in airway hyperresponsiveness. Chest. 1986 Oct;90(4):578–583. doi: 10.1378/chest.90.4.578. [DOI] [PubMed] [Google Scholar]
  15. Umezu K., Yuasa S., Sudoh A. Change of hepatic histamine content during hepatic fibrosis. Biochem Pharmacol. 1985 Jun 1;34(11):2007–2011. doi: 10.1016/0006-2952(85)90323-5. [DOI] [PubMed] [Google Scholar]
  16. Verburg K. M., Bowsher R. R., Henry D. P. A new radioenzymatic assay for histamine using purified histamine N-methyltransferase. Life Sci. 1983 Jun 20;32(25):2855–2867. doi: 10.1016/0024-3205(83)90322-3. [DOI] [PubMed] [Google Scholar]
  17. Verburg K. M., Bowsher R. R., Henry D. P. Kinetic analysis of the histamine N-methyltransferase reaction as used in the histamine radioenzymatic assay: optimization of assay specificity. Life Sci. 1984 Jul 16;35(3):241–251. doi: 10.1016/0024-3205(84)90107-3. [DOI] [PubMed] [Google Scholar]
  18. Wiesner R. H., LaRusso N. F., Ludwig J., Dickson E. R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985 Jan;88(1 Pt 1):108–114. doi: 10.1016/s0016-5085(85)80141-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES